Carfilzomib Resistance Due to ABCB1/MDR1 Overexpression Is Overcome by Nelfinavir and Lopinavir in Multiple Myeloma

Leukemia - United Kingdom
doi 10.1038/leu.2017.212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance

Blood Cancer Journal
OncologyHematology
2013English

Carfilzomib for Relapsed or Refractory Multiple Myeloma

The Lancet Oncology
Oncology
2018English

Productivity Costs Related to Bortezomib and Carfilzomib Administration for Multiple Myeloma in Finland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Resistance to the Translation Initiation Inhibitor Silvestrol Is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells

AAPS Journal
Pharmaceutical Science
2011English

Review New Drugs in Multiple Myeloma – Role of Carfilzomib and Pomalidomide

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2014English

HAX-1 Overexpression in Multiple Myeloma Is Associated With Poor Survival

British Journal of Haematology
Hematology
2018English

P Glycoprotein (MDR1; ABCB1; P-Gp; CD243)

Science-Business eXchange
2012English

P Glycoprotein (ABCB1; MDR1; P-Gp)

Science-Business eXchange
2009English

ABCB1 (MDR1) Induction Defines a Common Resistance Mechanism in Paclitaxel- And Olaparib-Resistant Ovarian Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy